Global expansion Recent regulatory approvals and international launches indicate Hermes Medical Solutions is expanding its Hermia platform across multiple markets, presenting opportunities to engage regional distributors, integrators, and hospitals seeking a unified imaging software that supports PET/SPECT/CT/MR workflows.

Dosimetry leadership Hermia’s advanced dosimetry capabilities, including voxel dosimetry and Hänscheid-based single-time-point dosimetry, position the company to target nuclear medicine and theranostics centers looking to optimize personalized treatment planning and operational efficiency.

Integrated solutions Partnerships to integrate Hermia with scanners like VERITON-CT and the emphasis on vendor-neutral, all-in-one software create sales potential with imaging departments that require seamless interoperability across equipment from different vendors.

Regulatory momentum Health Canada approval for the latest Hermia release signals readiness for widespread clinical adoption in North America and could be used to unlock pilot programs, reference sites, and accelerated procurement conversations with healthcare networks.

Workflow efficiency Hermia’s automation and remote workflow capabilities address demand for increased throughput and consistency in imaging review, offering a compelling value proposition for high-volume centers and hospital networks facing staffing and efficiency pressures.